课题基金 / 基金详情

China/UK/Thailand Program on Poultry Biosafety for Salmonella, E. coli and Campylobacter (CUT-SEC)

China/UK/Thailand Program on Poultry Biosafety for Salmonella, E. coli and Campylobacter (CUT-SEC)
中国/英国/泰国家禽沙门氏菌、大肠杆菌和弯曲杆菌生物安全项目 (CUT-SEC)
批准号:
BB/R012776/1
负责人:
Timothy Walsh
金额:
$197.82万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --

项目摘要

项目成果

Timothy Walsh的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The world's population is increasing, particularly in low-middle income countries and by 2050 as a global community we will have to feed an additional 2 billion people. This population explosion will place greater emphasis on meat production, particularly poultry. It is estimated by the world bank that by 2030, China, India and SE Asia will supply 80% of the world meat trade which will include national consumption and international export. The question is - how will this be met? Poultry farming will need to intensify to meet these global needs with the inevitable increase in antibiotic consumption used in animal feeds despite reservations from world authorities (WHO, FAO etc.). The AMR prevalence in chicken is considerably higher than other animal sectors due to the use of uncontrolled animal feeds and the potential for cross-contamination, either during growth or at slaughter. We use antibiotics to fatten and increase poultry growth yield yet this too in causing serious antibiotic resistance in human pathogens. Antimicrobial resistance (AMR) is now deemed to be the biggest global threat facing humanity in the 21C. AMR has taken center stage as a global health issue yet most non-specialists are unaware the impact AMR will have on global populations and the potential it has of taking the treatment of infections back to the "dark ages". Hitherto, most studies around the world studying the impact of AMR have been small, one dimensional and often biased - too focused on AMR bacteria as oppose to studying the whole bacterial population. To understand the impact of AMR in the poultry sector we have established a network in Nth Thailand and mid-Eastern China (Shandong) and will undertake a comprehensive sampling strategy to examine key human food pathogens (Campylobacter, Salmonella and E. coli) in farms, the environment (water, flies, wild-birds) and community (human normal flora) and infections (urinary tract infections and gastroenteritis). Our Study (called CUT-SEC) has a comprehensive sampling platform: work package (WP) 1, chicken and duck sampling from hatcheries to slaughter; WP2, flies and wild birds; WP3, water samples and seepage; WP4, domestic animals on or near farms; WP5 Normal human rectal flora; WP6 community infections. We will analyze at least 70 samples every 3 months to examine seasonal variation and sample from Nth Thailand and Shandong. Bacteria will be analyzed by basic microbiology techniques and selected to be whole genome sequenced where we can interrogate the bacteria's whole DNA and compare it to other bacteria to see if they have spread from one sector (e.g. flies) to another (e.g. humans). This study will also sequence all the bacteria in the human gut to understand the dynamics of AMR bacterial populations. We will also undertake controlled experiments in chicken farms to monitor the spread on SEC and use mathematical models to understand how AMR pathogens spread in animals and their impact on human infections. The impact of this CUT-SEC will have immense consequences for the animal, human and economic sectors in Thailand and China. Our network is well established, has a proven track record of working together in Thailand and China and expertise to undertake this exciting and challenging proposal.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/acsomega.2c07165
发表时间: 2023-03-07
期刊: ACS OMEGA
影响因子: 4.1
作者: [Hanpaibool, Chonnikan, Ngamwongsatit, Natharin, Ounjai, Puey, Yotphan, Sirilata, Wolschann, Peter, Mulholland, Adrian J., Spencer, James, Rungrotmongkol, Thanyada]
通讯作者: Rungrotmongkol, Thanyada
Strain and lineage-level methylome heterogeneity in the multi-drug resistant pathogenic Escherichia coli ST101 clone
多重耐药致病性大肠杆菌 ST101 克隆的菌株和谱系水平甲基化组异质性
DOI: 10.1101/2020.06.07.138552
发表时间: 2020
期刊:
影响因子: --
作者: [Ashcroft M]
通讯作者: Ashcroft M
DOI: 10.1093/cid/ciz1095
发表时间: 2020-10-23
期刊: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子: --
作者: [Andrey DO, Pereira Dantas P, Martins WBS, Marques De Carvalho F, Almeida LGP, Sands K, Portal E, Sauser J, Cayô R, Nicolas MF, Vasconcelos ATR, Medeiros EA, Walsh TR, Gales AC]
通讯作者: Gales AC
Antibiotic resistance, stewardship, and consumption - Authors' reply.
抗生素耐药性、管理和消费——作者的回复。
DOI: 10.1016/s2542-5196(18)30263-8
发表时间: 2019
期刊: The Lancet. Planetary health
影响因子: --
作者: [Collignon P]
通讯作者: Collignon P
The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin
  • 批准号:
    MR/Y033809/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $23.35万
  • 财政年份:
    2024
  • 负责人:
    Timothy Walsh
  • 依托单位:
Determining the clinical and environmental impact, burden and cost of Extensively Drug Resistant Enterobacteriaceae in China (DETER-XDRE-CHINA-HUB)
  • 批准号:
    MR/S013768/2
  • 项目类别:
    Research Grant
  • 资助金额:
    $175.04万
  • 财政年份:
    2020
  • 负责人:
    Timothy Walsh
  • 依托单位:
Determining the clinical and environmental impact, burden and cost of Extensively Drug Resistant Enterobacteriaceae in China (DETER-XDRE-CHINA-HUB)
  • 批准号:
    MR/S013768/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $235.14万
  • 财政年份:
    2019
  • 负责人:
    Timothy Walsh
  • 依托单位:
Determining the clinical and environmental impact, burden and cost of extensively drug resistant Enterobacteriaceae in China (DETER-XDRE-CHINA)
  • 批准号:
    MR/P007295/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $128.01万
  • 财政年份:
    2016
  • 负责人:
    Timothy Walsh
  • 依托单位:
国内基金
海外基金
LncRNA-lincUK介导邻近基因UK组蛋白修 饰调控褐飞虱繁殖力的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    刘凯
  • 依托单位:
CREKA/rhPro-UK靶向载药微泡在腔内超声场下对静脉血栓的除栓作用及机理研究
EEID:US-UK-China: 新发禽流感病毒的演进与生态传播动力学的前瞻性研究
抗真菌药物UK-2A的组合生物合成研究
  • 批准号:
    31970054
  • 项目类别:
    面上项目
  • 资助金额:
    62.0万元
  • 批准年份:
    2019
  • 负责人:
    瞿旭东
  • 依托单位: